UK’s NICE backs Pradaxa for AF: http://www.reuters.com/article/2011/11/01/britain-pradaxa-idUSL5E7LV39L20111101 NICE endorsed Pradaxa for VTE prevention—the drug’s first approved indication in Europe—three years ago (#msg-32382343).